首页> 美国卫生研究院文献>Viruses >Gene Editing in Human Lymphoid Cells: Role for Donor DNA Type of Genomic Nuclease and Cell Selection Method
【2h】

Gene Editing in Human Lymphoid Cells: Role for Donor DNA Type of Genomic Nuclease and Cell Selection Method

机译:人类淋巴细胞中的基因编辑:供体DNA的作用基因组核酸酶的类型和细胞选择方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Programmable endonucleases introduce DNA breaks at specific sites, which are repaired by non-homologous end joining (NHEJ) or homology recombination (HDR). Genome editing in human lymphoid cells is challenging as these difficult-to-transfect cells may also inefficiently repair DNA by HDR. Here, we estimated efficiencies and dynamics of knockout (KO) and knockin (KI) generation in human T and B cell lines depending on repair template, target loci and types of genomic endonucleases. Using zinc finger nuclease (ZFN), we have engineered Jurkat and CEM cells with the 8.2 kb human immunodeficiency virus type 1 (HIV-1) Env genome integrated at the adeno-associated virus integration site 1 (AAVS1) locus that stably produce virus particles and mediate infection upon transfection with helper vectors. Knockouts generated by ZFN or clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) double nicking techniques were comparably efficient in lymphoid cells. However, unlike polyclonal sorted cells, gene-edited cells selected by cloning exerted tremendous deviations in functionality as estimated by replication of HIV-1 and human T cell leukemia virus type 1 (HTLV-1) in these cells. Notably, the recently reported high-fidelity eCas9 1.1 when combined to the nickase mutation displayed gene-dependent decrease in on-target activity. Thus, the balance between off-target effects and on-target efficiency of nucleases, as well as choice of the optimal method of edited cell selection should be taken into account for proper gene function validation in lymphoid cells.
机译:可编程核酸内切酶在特定位点引入DNA断裂,可通过非同源末端连接(NHEJ)或同源重组(HDR)修复。人类淋巴样细胞中的基因组编辑具有挑战性,因为这些难以转染的细胞也可能无法通过HDR有效修复DNA。在这里,我们估计人T和B细胞系中敲除(KO)和敲入(KI)代的效率和动力学,具体取决于修复模板,靶基因座和基因组内切核酸酶的类型。我们使用锌指核酸酶(ZFN),设计了在腺相关病毒整合位点1整合了8.2 kb人类免疫缺陷病毒1型(HIV-1)Δ Env基因组的Jurkat和CEM细胞( AAVS1)基因座,在用辅助载体转染后稳定产生病毒颗粒并介导感染。 ZFN或簇状规则间隔的短回文重复序列(CRISPR / Cas9)双切口技术产生的敲除在淋巴样细胞中相当有效。但是,与多克隆分选的细胞不同,通过克隆选择的基因编辑细胞在功能上产生了巨大的偏差,如通过在这些细胞中复制HIV-1和1型人类T细胞白血病病毒(HTLV-1)所估计的那样。值得注意的是,最近报道的高保真eCas9 1.1当与切口酶突变结合时,显示出靶标活性的基因依赖性降低。因此,应考虑到核酸酶的脱靶效应和脱靶效率之间的平衡,以及编辑细胞选择的最佳方法的选择,以便在淋巴样细胞中进行适当的基因功能验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号